![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, April 29, 2010 12:01:19 PM
Paradigm Medical Industries, Inc. (PINKSHEETS: PDMI) announced today that Stephen L. Davis, the Company's President and CEO, will be attending ARVO, an ophthalmic research and product development meeting to be held in Ft. Lauderdale, Florida from May 1-5, 2010. Paradigm will utilize this meeting to introduce its new Paramax, which remains under FDA review, and its FDA approved Blood Flow Analyzer(TM) as new and innovative diagnostic devices for early detection of glaucoma. Mr. Davis will also meet with representatives from other ophthalmic research organizations to discuss opportunities for Paradigm to participate in new product development partnerships.
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM